Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
96pct
303d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Freedom to Compete Act This bill amends the Fair Labor Standards Act of 1938 to prohibit an employer from enforcing, or threatening to enforce, any non-compete agreement in employment contracts with certain entry level, lower wage workers. A non-compete agreement entered into before the enactment of this bill shall be void and have no effect.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2023 · first_quarter · Veterans
Veterans Benefits Administration: Lobbied for changes to and oversight of Veterans Benefits Administration's (VBA) employee performance standards. Lobbied for increased oversight and changes to performance standards for Legal Administrative Assistants in the VBA National Call Centers. Lobbied for comprehensive changes to internal VBA processes for claims, including changes to the VBA National Work Queue. Lobbied to require the VA to include VA employee input when making changes to the claims process, employee performance standards, and training for claims processors. Lobbied on the processing of complex claims within the Veterans Benefits Administration, including how it relates to Military Sexual Trauma, Traumatic Brain Injury, and catastrophic injury claims. Lobbied for the specialization of claims processing for highly complex cases. Board of Veterans Appeals: Lobbied for reimbursement for Bar Membership dues for attorneys working at the Board of Veterans' Appeals. Lobbied for the re-instatement of GS-14 career ladder position. Lobbied for the creation of a journeyman GS-15 position. Lobbied for the re-instatement of experience requirements for Board of Veterans Appeals Members (Veterans Law Judgements), Lobbied in support of and for changes to H.R.1378, the Veterans Appeals Backlog Improvement Act. C&P Exams: Lobbied against contracting out of Compensation and Pension (C&P) Exams and bringing those exams back into the VA. Lobbied to keep all specialty C&P Exams including but not limited to Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), Military Sexual Trauma (MST), veterans who served as Prisoners of War (POWs), veterans who suffered catastrophic injuries, and veterans who are currently eligible to pursue toxic exposure claims. Lobbied for the VA to utilize more internal C&P Providers by hiring more staff and returning staff to C&P positions who had previously been reassigned. Lobbied to keep Integrated Disability Evaluation System (IDES) Exams within the VA. Lobbied for the continued oversight of contract C&P Exams. Lobbied to make C&P Exams available in every VA Medical Center. Lobbied to make sure the VA is in compliance with Section 2002 of the Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020. Collective Bargaining Rights: Lobbied for the reintroduction of the "Protecting VA Employees Act" to repeal parts of the VA Accountability Act. Lobbied for the reintroduction of the "VA Employee Fairness Act." VA HR Modernization: Lobbied to address problems created by VA reorganization of its human resources processes including centralization and implementation of new information technology systems, and practices and policies related to filling and posting unfilled positions. Lobbied to have Congress require the VA to return the HR functions back to VA facilities and to appropriate funding for it. VA Compensation: Lobbied in support of H.R. 536/S. 124, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of H.R. 866/S. (pending reintroduction) the "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 82/S. 597, the Social Security Fairness Act to protect VA employees affected by the Windfall Elimination Provision (WEP) and the Government Pension Offset (GPO). Lobbied in support of H.R. 543, the "VA CPE Modernization Act." Lobbied in support of H.R. 1322/S. (pending reintroduction), the Law Enforcement Officers Equity Act as it pertains to VA Police Officers. VA Asset Infrastructure Review (AIR) Act: Lobbied for restriction on VAs authority to close or reduce services at rural healthcare facilities in the 2024 VA Military Construction appropriations bill. Lobbied against continued increased spending on community care at the expense of VAs own staffing and infrastructure. Lobbied against Congress codifying the community access standards that create a bias toward referral to community care over VAs own healthcare. Testimony, Statements for the Record, and Letters: Provided a Statement for the Record for the House Veterans Affairs Committee hearing Building an Accountable VA: Applying Lessons Learned to Drive Future Success on February 28, 2023. Provided a Statement for the Record for the House Veterans Affairs Committee Subcommittee on Oversight and Investigations hearing on Accountability at VA: Leadership Decisions Impacting its Employees and Veterans on March 9, 2023. Provided a Statement for the Record for the Senate Veterans Affairs Committee hearing on Strengthening Methods of Recruitment and Retention for VAs Workforce, March 22, 2023. Provided comments to the House Veterans Affairs Committee Subcommittee hearing for a March 29, 2023, legislative hearing on: H.R. 41 VA Same-Day Scheduling Act of 2023; H.R. 754, Modernizing Veterans Health Care Eligibility Act; and H.R. 542, Elizabeth Dole Home-and Community-Based Services for Veterans and Caregivers Act. Provided comments to Senate Veterans Affairs Committee for February 16, 2023, markup of S.10, The VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act. Provided questions to committee members for the House Appropriations Committee, subcommittee on Military Construction, Veterans Affairs, and Related Agencies, March 29, 2023. Specific Legislation: Lobbied for reintroduction of the "VA Employee Fairness Act." Lobbied in support of H.R. 536/S. 124, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of H.R. 866/S. (pending reintroduction) "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 82/S. 597, the Social Security Fairness Act to protect VA employees affected by the Windfall Elimination Provision (WEP) and the Government Pension Offset (GPO). Lobbied in support of H.R. 543, the "VA CPE Modernization Act." Lobbied in support of H.R. 1322/S. (pending reintroduction), the Law Enforcement Officers Equity Act as it pertains to VA Police Officers. Lobbied in support of and for changes to H.R.1378, the Veterans Appeals Backlog Improvement Act. Lobbied for changes to S. 10 the " VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023. Lobbied for changes to S. 10, the "VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act related to market pay, performance pay, cost of living adjustments, licensure and certification reimbursement, COVID leave flexibility, and recruitment and retention at VA community living centers. Also lobbied for specific changes to the bill related to the inclusion of VA Police Pensions, Continuing Professional Education Benefits, and Collective Bargaining Rights for Title 38 Employees. Lobbied to renew a defunded corpsmen and medic vocational education and training program Grow Our Own. Lobbied for the reintroduction of the "Protecting VA Employees Act" to amend parts of the VA Accountability and Whistleblower Protection Act. Lobbied for oversight of the Honoring Our PACT Act.
Committee on Small Business and Entrepreneurship. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2020 · second_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Client expense: $190,000 · Firm income: Not reported
Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act
Client expense: $156,610 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Dept. of Labor Independent Contractor Rulemaking H.R.8375 Worker Flexibility and Small Business Protection Act S.4738 Worker Flexibility and Small Business Protection Act
Client expense: $230,000 · Firm income: Not reported
Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office
2020 · third_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Client expense: $180,000 · Firm income: Not reported
Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office
2020 · second_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Client expense: $190,000 · Firm income: Not reported
Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act
Client expense: $156,610 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Client expense: $190,000 · Firm income: Not reported
Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act
Client expense: $156,610 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2019 · fourth_quarter · Labor Issues/Antitrust/Workplace
H.R. 2474, Protecting the Right to Organize Act S. 1306, Protecting the Right to Organize Act NLRB Rulemaking on joint employer Dept. of Labor Rulemaking on joint employer S. 124, Freedom to Compete Act
Client expense: $380,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA)
2019 · second_quarter · Pharmacy
Implementation of Food and Drug Administration Reauthorization Act (FDARA). Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Drug Compounding. Drug Shortages. Biosimilars Naming. Biosimilars Insulin. Pass Through Payments for Biosimilars. Prescription Drug Costs. American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Proposed Anti-Kickback Statute (AKS) Rebates. FDA Citizen Petitions. H.R.985: FAST Generics Act of 2019. H.R.1506: FAIR Generics Act. H.R.1503: Orange Book Transparency Act of 2019. H.R.1520: Purple Book Continuity Act of 2019. S.61: Safe and Affordable Drugs from Canada Act of 2019. S.64: Preserve Access to Affordable Generics and Biosimilars Act. S.1416: Affordable Prescriptions for Patients Act of 2019. S.1224: Stop STALLING Act. H.R.447/S.97: Affordable and Safe Prescription Drug Importation Act. S.124: Freedom to Compete Act. H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019. H.R.938: Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019. H.R.465/S.102: Prescription Drug Price Relief Act of 2019. H.R.1093/S. 378: Stop Price Gouging Act. S.474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019. S.475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019. S.476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019. S.440: Preserving Access to Cost Effective Drugs (PACED) Act. S.1895: Lower Health Care Costs Act. H.R.965/S.340: CREATES Act of 2019. Public Law 115-123: Bipartisan Budget Act of 2018. Risk Evaluation and Mitigation Strategies (REMS). Pharmaceutical Exclusivity. Biologic Exclusivity. H.R.3379: Price Relief, Innovation, and Competition for Essential Drugs Act. S.659: Biologic Patent Transparency Act. Biologics Price Competition and Innovation Act (BPCIA). Public Law 115-52: FDA Reauthorization Act of 2017.
2019 · first_quarter · Pharmacy
Implementation of Food and Drug Administration Reauthorization Act (FDARA). Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Drug Compounding. Drug Shortages. Biosimilars Naming. Biosimilars Insulin. Pass Through Payments for Biosimilars. Prescription Drug Costs. American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. H.R.985: FAST Generics Act of 2019. H.R.1506: FAIR Generics Act. H.R.1503: Orange Book Transparency Act of 2019. H.R.1520: Purple Book Continuity Act of 2019. S.61: Safe and Affordable Drugs from Canada Act of 2019. S.64: Preserve Access to Affordable Generics and Biosimilars Act. H.R.447/S.97: Affordable and Safe Prescription Drug Importation Act. S.124: Freedom to Compete Act. H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019. H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019. H.R.465/S.102: Prescription Drug Price Relief Act of 2019. H.R.1093/S. 378: Stop Price Gouging Act. S.474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019. S.475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019. S.476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019. S.440: Preserving Access to Cost Effective Drugs (PACED) Act. H.R.965/S.340: CREATES Act of 2019. Public Law 115-123: Bipartisan Budget Act of 2018. Risk Evaluation and Mitigation Strategies (REMS). Pharmaceutical Exclusivity. Biologic Exclusivity. S.659: Biologic Patent Transparency Act. Biologics Price Competition and Innovation Act (BPCIA). Public Law 115-52: FDA Reauthorization Act of 2017.
Client expense: $1,130,000 · Firm income: Not reported
Client expense: $1,100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)